Navigation Links
Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences
Date:12/1/2011

PM.  Details on this presentation and additional data presentations are below:

Presentation Date/Time: Sunday, December 11 from 6:00 PM - 8:00 PM
Poster Title: The HDAC Inhibitor Entinostat (SNDX-275) Induces Clinical Responses in Patients with Relapsed and Refractory Hodgkin's Lymphoma: Results of ENGAGE-501 Multicenter Phase 2 Study 
Program/Session: Oral and Poster Abstracts, 624. Lymphoma- Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II
Abstract Number: 2715

Presentation Date/Time: Saturday, December 10, 2011: 5:30 PM-7:30 PM
Poster Title: HDAC and LSD1 Inhibitors Synergize to Induce Cell Death in Acute Leukemia Cells
Program/Session: Oral and Poster Abstracts, 604. Molecular Pharmacology, Drug Resistance: Poster I
Abstract Number: 1427
Location: Hall GH (San Diego Convention Center)

Presentation Date/Time: Monday, December 12 from 6:00 PM - 8:00 PM
Poster Title: Entinostat, a Novel Histone Deacetylase (HiDAC) Inhibitor Enhances the Anti-Tumor Activity of Bortezomib (BTZ) in Rituximab-Chemotherapy Sensitive and Resistant Lymphoma Cell Lines
Program/Session: Oral and Poster Abstracts, 625. Lymphoma - Pre-Clinical - Chemotherapy and Biologic Agents: Poster III
Abstract Number: 3734
Location: Hall GH (San Diego Convention Center)

Breast Cancer and Hormone Therapy
Annually about 207,000 women have breast cancer in the United States and about 20,000 of them have metastatic breast cancer (MBC).  Approximately 70 percent of women with breast cancer have ER+ breast cancer.  Blocking estrogen activity with aromatase inhibitors represe
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
2. Multiple Programs from Merrimack Pharmaceuticals Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
4. Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
5. Biogen-Idecs BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis
6. Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
7. Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
8. DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Calipers LabChip® Dx Platform
9. Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug
10. S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis
11. Phase 1 / 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma Published in the Journal of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE ( Europe ... Glasgow Science Centre in Scotland , ... the SynCardia temporary Total Artificial Heart powered ... $3 million Bodyworks Exhibition, one of the most advanced ...
(Date:5/23/2013)... May 23, 2013 InspireMD, ... the leader in embolic protection stents, today announced ... Acute ST Elevation Reperfusion) trial demonstrating that the ... and drug eluting stents in all-cause mortality in ... from the trial were presented at the InspireMD ...
(Date:5/23/2013)... 2013  PAREXEL International Corporation (NASDAQ: PRXL ... the Jefferies Healthcare Conference in New York.  ... Financial Officer, will be making a presentation on PAREXEL ... June 3, 2013. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
Breaking Medicine Technology:Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5PAREXEL International To Present At Jefferies Healthcare Conference 2
... , , , , ... a Bay(R) Pharmaceuticals , Inc. (NYSE-Amex: NBY ... treatment or prevention of a wide range of bacterial, viral, and ... Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, ...
... , , , ... (Nasdaq: WHRT ) - World Heart Corporation (WorldHeart) announced today ... of the Levacor Ventricular Assist Device (VAD) at ten US centers. ... information to the FDA within 45 days, but the study is permitted to ...
Cached Medicine Technology:NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 2NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 3WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD 2WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD 3
(Date:5/23/2013)... United States Vice President Dick Cheney served as the ... , In front of 1,500 guests yesterday at ... "I am delighted to be here to have the ... Year Award. I think it's a tremendous recognition; I ... company like this because there are obviously a great ...
(Date:5/23/2013)... 23, 2013 Jeanne Ettelson, president of ... its popular and only free OCD support group in ... resource for OCD sufferers, the group is lead by ... disorders. This allows group participants to learn accurate ... Response Prevention. , “Participants in Beyond OCD’s support ...
(Date:5/23/2013)... News) -- The sensation of itching is hardwired into ... a small molecule released in the spinal cord, according ... say this molecule, known as natriuretic polypeptide b (Nppb), ... system. Ultimately, this signal is experienced as an itch. ... similar, the researchers concluded that a similar process probably ...
(Date:5/23/2013)... May 23 (HealthDay News) -- Although a study ... the thinking and memory problems associated with Alzheimer,s ... have been unable to duplicate those findings. ... implications for patient safety since the drug involved ... effects, such as major blood-lipid abnormalities, pancreatitis, headaches, ...
(Date:5/23/2013)... Netsmart today announced it is ranked #49 ... technology (HIT) providers for 2013. , The HCI 100 listing ... Informatics magazine. Netsmart’s ranking of #49 is up from ... is largely due to our commitment to helping organizations forge ... resources are scarce, the demand for care is unprecedented and ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Netsmart Named to Healthcare Informatics Top 100 List 2
... already collaborating on several projects, including the mapping of ... bacteria, compiled from 577 billion base pairs of sequence ... this work as one of the scientific breakthroughs of ... in life sciences, healthcare and agricultural research. Henry ...
... In their search for new, better ways to diagnose ... discovered that measurement of C-reactive protein in the synovial ... white blood cell count (WBC) and the percentage of ... minimal role in the determination of PJI. , The ...
... HealthDay Reporter , MONDAY, Feb. 6 (HealthDay News) -- ... diabetes, the first line of defense is lifestyle changes such ... those lifestyle changes don,t get blood sugar levels under control, ... as the first oral treatment that should be given. ...
... have, for the first time, described the genetic basis of ... by chronic pelvic pain and infertility. The researchers, discovery of ... Published in the Feb. 3 early online issue of ... mutation located in part of the KRAS gene, which leads ...
... HealthDay Reporter , MONDAY, Feb. 6 (HealthDay News) -- ... in cars, more than 20 percent of nonsmoking teens still ... particularly intense in a closed space, such as inside a ... "There have been marked decreases in exposure to smoking ...
... , MONDAY, Feb. 6 (HealthDay News) -- ... processing information in men, but not in women, new research ... more reason to quit the habit. "This study underscores ... smoking is a modifiable risk factor with an effect size ...
Cached Medicine News:Health News:VIB and BGI organize joint genomics meeting, Feb. 15, 2012, Belgium 2Health News:VIB and BGI organize joint genomics meeting, Feb. 15, 2012, Belgium 3Health News:Metformin Preferred Drug for Type 2 Diabetes, Experts Say 2Health News:Metformin Preferred Drug for Type 2 Diabetes, Experts Say 3Health News:Gene mutation discovery sparks hope for effective endometriosis screening 2Health News:Fewer Teens Exposed to Tobacco Smoke in Cars: Report 2Health News:Fewer Teens Exposed to Tobacco Smoke in Cars: Report 3Health News:Smoking May Be Especially Tough on Men's Brains 2
... When Welch Allyn designed the ... in 1915, they began a tradition ... eye care professionals worldwide. In keeping ... introduces the prestigious 3.5v Coaxial-plus Ophthalmoscope. ...
Welch Allyn quality in a convenient pocket size. The PocketScope fits into your pocket! Easy to use, lightweight, and perfect for general and specialist use. Take your PocketScope with you everywhere...
... ALE-3600 and ALE-3600PC Patternless ... fit lenses to frames, ... the convenience of complete ... edgers are particularly suited ...
... the features of the FR-20 Frame Reader with ... no longer need to connect the frame reader ... capable of receiving data via a cable from ... to streamline your edging operations. It stores the ...
Medicine Products: